RedHill Biopharma (RDHL) Earnings Date, Estimates & Call Transcripts → Guard Against the Coming Financial Upheaval (From Porter & Company) (Ad) Free RDHL Stock Alerts $0.47 -0.01 (-2.07%) (As of 05/17/2024 ET) Add Compare Share Share EarningsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRDHL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RDHL Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad The Freeport SocietyNext President (Not Trump. Not Biden.)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump.Click here to see why it will be ______ _________. RDHL Earnings Date and InformationRedHill Biopharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, June 10th, 2024 based off prior year's report dates.Read More Get RedHill Biopharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for RDHL and its competitors with MarketBeat's FREE daily newsletter. RedHill Biopharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 6/10/2024Estimated)------- 8/17/2023Q2 2023-$36.00+$36.00$36.00-$1.80 million6/12/2023Q1 2023-$5.87+$5.87($8.26)-$3.60 million11/29/2022Q3 2022($12.00)($22.40)($10.40)($0.56)-$17.55 million11/7/2022Q2 2022-($8.00)($8.00)($0.20)-$18.35 million6/23/2022Q1 2022($16.00)($12.00)+$4.00($0.30)-$18.24 million 3/17/2022Q4 2021($16.00)($20.00)($4.00)($0.50)$22.99 million$22.07 million Get the Latest News and Ratings for RDHL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RedHill Biopharma and its competitors with MarketBeat's FREE daily newsletter. 11/30/2021Q3 2021($19.20)($20.00)($0.80)($0.46)$23.41 million$21.61 million 8/25/2021Q2 2021($16.00)($24.00)($8.00)($0.62)$23.15 million$21.50 million 5/26/2021Q1 2021($13.60)($2.00)+$11.60($0.53)$22.37 million$20.58 million RedHill Biopharma Earnings - Frequently Asked Questions When is RedHill Biopharma's earnings date? RedHill Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, June 10th, 2024 based off last year's report dates. Learn more on RDHL's earnings history. How much revenue does RedHill Biopharma generate each year? RedHill Biopharma (NASDAQ:RDHL) has a recorded annual revenue of $6.53 million. How much profit does RedHill Biopharma generate each year? RedHill Biopharma (NASDAQ:RDHL) has a recorded net income of $23.92 million. RDHL has generated $0.00 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Avalo Therapeutics Earnings Pieris Pharmaceuticals Earnings Monopar Therapeutics Earnings Kiora Pharmaceuticals Earnings Purple Biotech Earnings FSD Pharma Earnings Edesa Biotech Earnings Imunon Earnings Elevai Labs Earnings Moleculin Biotech Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution This page (NASDAQ:RDHL) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingNext President (Not Trump. Not Biden.)The Freeport SocietyMissed NVDA? Buy this AI stock NOWChaikin AnalyticsMost important medical advance in 100 yearsThe Oxford Club41 banks launch ‘crypto dollar’Stansberry ResearchDems have chosen Biden replacement?Paradigm PressWhat’s Really Next for America…Porter & CompanyBreaking News: Elon Musk Invents New Type of A.I. (Shocking)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RedHill Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.